Updated links and drug labels

Framework and content updates

Mandatory framework update

Updated Framework Updated and link to Privacy Policy

- Updated links to partner sites and content.

Updated links to partner sites and content, no significant functionality updates.

Updated links, support email, etc. to reflect mobile application parent site web address change to https://remm.hhs.gov, no significant functionality updates.

- Added "Platelet cytokine" page - Updated links in the Emergency Contacts page for RAP

Added 5 videos. Added video timestamps/chapters where available. Content updates

Improved navigation, better support for platform specific features and newer devices Content updates Bug fixes and general improvements

Improved navigation, better support for platform specific features and newer devices Content updates Bug fixes and general improvements

• Updated content about the use of myeloid cytokines for the treatment of the hematopoietic sub-syndrome of the Acute Radiation Syndrome (ARS). • Updated the medical management algorithms for contamination and contamination + exposure

1.Easier input of date/time and lymphocyte count in “Dose Estimator” and “Scarce Resources” Tools 2.Results of Dose Estimator and Scarce Resources Triage Tool easily captured on single screen 3.Zooming in/out enabled, especially helpful on algorithm pages 4.Landscape view now enabled for easier reading, especially helpful on algorithm pages 5.Design improvements: clearer fonts, better colors 6.Updated Emergency Contacts information for government resources 7.Updated links to REMM web site 8.Clearer presentation of medical disclaimers 9.Minor bug fixes in Version 2.1.1

1.Easier input of date/time and lymphocyte count in “Dose Estimator” and “Scarce Resources” Tools 2.Results of Dose Estimator and Scarce Resources Tools easily captured on single screen 3.Zooming in/out enabled, especially helpful on algorithm pages 4.Landscape view now enabled for easier reading, especially helpful on algorithm pages 5.Design improvements: clearer fonts, better colors 6.Updated Emergency Contacts information for government resources 7.Updated links to REMM web site 8.Clearer presentation of medical disclaimers 9.Bug fixes

Version 2.0.3 has updated myeloid cytokines information based on FDA approval of second countermeasure for the indication of acute exposure to myelosuppressive doses of radiation. There are now 2 drugs that are FDA approved for this indication: Neupogen and Neulasta. Version 2.0.4 is a minor technical update of the app.

Updated myeloid cytokines information based on FDA approval of second countermeasure for the indication of acute exposure to myelosuppressive doses of radiation. There are now 2 drugs that are FDA approved for this indication: Neupogen and Neulasta.

Correction of version number

New information from the FDA about countermeasure newly approved for radiation-induced myelosuppression

Update to content related to management algorithms

* Version 2.0 of Mobile REMM is a completely redesigned App for easier use and faster navigation. * Dose Estimator: faster data entry for vomiting and lymphocyte depletion kinetics tools * Scarce Resources for Interactive Triage Tool for Use after IND Detonation * SALT triage system for radiation emergencies * Updated emergency contact information

1. Updates to Isotopes of Interest 2. Links to REMM YouTube videos

Resolves problems in iPhone5

Tool for radiation unit conversion Updates to Emergency Contacts

- Updated algorithm for Diagnosing and Managing Radiation Contamination: how to manage bioassay specimens - New section: Understanding Radiation Units

New algorithm for managing radiation exposure and acute radiation syndrome.